BioCrude Technologies USA, Inc. Debt Instrument, Convertible, Beneficial Conversion Feature
BioCrude Technologies USA, Inc. reported Debt Instrument, Convertible, Beneficial Conversion Feature of $33.33 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-20.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature · last filed 2020-03-20
- BioCrude Technologies USA, Inc. debt instrument, convertible, beneficial conversion feature for the quarter ending 2019-03-31 was $16.67K, a 13.37% decline year-over-year.
- BioCrude Technologies USA, Inc. debt instrument, convertible, beneficial conversion feature for the quarter ending 2018-12-31 was $6.57K, a 20.19% decline year-over-year.
- BioCrude Technologies USA, Inc. debt instrument, convertible, beneficial conversion feature for the quarter ending 2018-09-30 was $0.00.
- BioCrude Technologies USA, Inc. debt instrument, convertible, beneficial conversion feature for the quarter ending 2018-06-30 was $100.00.
- BioCrude Technologies USA, Inc. debt instrument, convertible, beneficial conversion feature for fiscal 2019 was $33.33K, a 28.67% increase from fiscal 2018.
- BioCrude Technologies USA, Inc. debt instrument, convertible, beneficial conversion feature for fiscal 2018 was $25.91K, a 77.69% increase from fiscal 2017.
- BioCrude Technologies USA, Inc. debt instrument, convertible, beneficial conversion feature for fiscal 2017 was $14.58K.
| Period end | Debt Instrument, Convertible, Beneficial Conversion Feature 3 month | Debt Instrument, Convertible, Beneficial Conversion Feature 6 month | Debt Instrument, Convertible, Beneficial Conversion Feature 9 month | Debt Instrument, Convertible, Beneficial Conversion Feature 12 month | Debt Instrument, Convertible, Beneficial Conversion Feature 12 month as first filed |
|---|---|---|---|---|---|
| 2019-12-31 | $33.33K 10-K · filed 2020-03-20 | ||||
| 2019-03-31 | $16.67K 10-Q · filed 2019-11-13 | $23.23K derived: sum of 2 quarters · filed 2020-03-20 | $23.23K derived: sum of 3 quarters · filed 2020-03-20 | $23.33K derived: sum of 4 quarters · filed 2020-03-20 | |
| 2018-12-31 | $6.57K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20 | $6.57K derived: sum of 2 quarters · filed 2020-03-20 | $6.67K derived: sum of 3 quarters · filed 2020-03-20 | $25.91K 10-K · filed 2020-03-20 | $25.91K 10-K · filed 2019-04-17 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $100.00 derived: sum of 2 quarters · filed 2018-11-08 | $19.34K 10-Q · filed 2018-11-08 | $27.57K derived: sum of 4 quarters · filed 2019-08-12 | |
| 2018-06-30 | $100.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-24 | $19.34K 10-Q · filed 2018-08-24 | $27.57K derived: sum of 3 quarters · filed 2019-08-12 | $27.57K derived: sum of 4 quarters · filed 2019-08-12 | |
| 2018-03-31 | $19.24K 10-Q · filed 2019-08-12 | $27.47K derived: sum of 2 quarters · filed 2019-08-12 | $27.47K derived: sum of 3 quarters · filed 2019-08-12 | ||
| 2017-12-31 | $8.23K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-17 | $8.23K derived: sum of 2 quarters · filed 2019-04-17 | $14.58K 10-K · filed 2019-04-17 | $6.35K 10-K · filed 2018-03-27 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $6.35K 10-Q · filed 2018-11-08 | |||
| 2017-06-30 | $6.35K 10-Q · filed 2018-08-24 |